Aflibercept in combination with docetaxel for second line treatment of locally advanced or metastatic non small cell lung cancer NSCLC Final results of a multinational placebo controlled phase III trial EFC10261 VITAL

Bildiriler > Özet Bildiri · 2011

Yazarlar: S Novello, R Ramlau, VA Gorbunova, TE Ciuleanu, Ö Ozguroglu, Tuncay GÖKSEL, C Baldotto, J Bennouna, FA Shepherd, G Scagliotti

The 13th World Conference on Lung Cancer, Hollanda, Uluslararası, Özet Bildiri, 2011-2011